Functional and molecular identification of a novel chloride conductance in canine colonic smooth muscle.
Swelling-activated or volume-sensitive Cl- currents are found in numerous cell types and play a variety of roles in their function; however, molecular characterization of the channels is generally lacking. Recently, the molecular entity responsible for swelling-activated Cl- current in cardiac myocytes has been identified as ClC-3. The goal of our study was to determine whether such a channel exists in smooth muscle cells of the canine colon using both molecular biological and electrophysiological techniques and, if present, to characterize its functional and molecular properties. We hypothesized that ClC-3 is present in colonic smooth muscle and is regulated in a manner similar to the molecular entity cloned from heart. Indeed, the ClC-3 gene was expressed in colonic myocytes, as demonstrated by reverse transcriptase polymerase chain reaction performed on isolated cells. The current activated by decreasing extracellular osmolarity from 300 to 250 mosM was outwardly rectifying and dependent on the Cl- gradient. Current magnitude increased and reversed at more negative potentials when Cl- was replaced by I- or Br-. Tamoxifen ([Z]-1-[p-dimethylaminoethoxy-phenyl]-1,2-diphenyl-1-butene; 10 microM) and DIDS (100 microM) inhibited the current, whereas 25 microM niflumic acid, 10 microM nicardipine, and Ca2+ removal had no effect. Current was inhibited by 1 mM extracellular ATP in a voltage-dependent manner. Cl- current was also regulated by protein kinase C, as phorbol 12,13-dibutyrate (300 nM) decreased Cl- current magnitude, while chelerythrine chloride (30 microM) activated it under isotonic conditions. Our findings indicate that a current activated by hypotonic solution is present in colonic myocytes and is likely mediated by ClC-3. Furthermore, we suggest that the ClC-3 may be an important mechanism controlling depolarization and contraction of colonic smooth muscle under conditions that impose physical stress on the cells.
Dick
G M
GM
Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, Nevada 89557, USA.
Bradley
K K
KK
Horowitz
B
B
Hume
J R
JR
Sanders
K M
KM
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D000818:Animals; D001965:Bromides / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002478:Cells, Cultured; D018118:Chloride Channels / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D002712:Chlorides / Q000378:metabolism*; D003106:Colon / Q000502:physiology*; D004285:Dogs; D005260:Female; D007038:Hypotonic Solutions; D007454:Iodides / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D009130:Muscle, Smooth / Q000502:physiology*; D009529:Nicardipine / Q000494:pharmacology; D009544:Niflumic Acid / Q000494:pharmacology; D009994:Osmolar Concentration; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013629:Tamoxifen / Q000494:pharmacology
D001965:Bromides; D002121:Calcium Channel Blockers; D018118:Chloride Channels; D002712:Chlorides; C115376:ClC-3 channel; D007038:Hypotonic Solutions; D007454:Iodides; D013629:Tamoxifen; D009544:Niflumic Acid; D009529:Nicardipine; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid